Document Detail


Integrative cancer epidemiology--the next generation.
MedLine Citation:
PMID:  23230187     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We outline an integrative approach to extend the boundaries of molecular cancer epidemiology by integrating modern and rapidly evolving "omics" technologies into state-of-the-art molecular epidemiology. In this way, one can comprehensively explore the mechanistic underpinnings of epidemiologic observations in cancer risk and outcome. We highlight the exciting opportunities to collaborate across large observational studies and to forge new interdisciplinary collaborative ventures.
Authors:
Margaret R Spitz; Neil E Caporaso; Thomas A Sellers
Related Documents :
23695927 - Employment challenges for cancer survivors.
23646507 - In vitro investigation on the magnetic thermochemotherapy mediated by magnetic nanopart...
24183727 - Fruit and vegetable consumption associated with reduced risk of epithelial ovarian canc...
24687637 - Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.
10498557 - Clinical utility of a rapid whole-blood d-dimer assay in patients with cancer who prese...
23096757 - Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Cancer discovery     Volume:  2     ISSN:  2159-8290     ISO Abbreviation:  Cancer Discov     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-11     Completed Date:  2013-08-13     Revised Date:  2013-12-04    
Medline Journal Info:
Nlm Unique ID:  101561693     Medline TA:  Cancer Discov     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1087-90     Citation Subset:  IM    
Copyright Information:
©2012 AACR.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Molecular Epidemiology / methods*
Neoplasms / epidemiology*,  genetics
Grant Support
ID/Acronym/Agency:
CA127219/CA/NCI NIH HHS; CA55769/CA/NCI NIH HHS; R01 CA055769/CA/NCI NIH HHS; R01 CA127219/CA/NCI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hello out there...Is anybody listening?
Next Document:  Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.